CN101953893A - Traditional Chinese medicine for treating cirrhosis - Google Patents
Traditional Chinese medicine for treating cirrhosis Download PDFInfo
- Publication number
- CN101953893A CN101953893A CN2010105144523A CN201010514452A CN101953893A CN 101953893 A CN101953893 A CN 101953893A CN 2010105144523 A CN2010105144523 A CN 2010105144523A CN 201010514452 A CN201010514452 A CN 201010514452A CN 101953893 A CN101953893 A CN 101953893A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- parts
- gram
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating cirrhosis, and belongs to the field of traditional Chinese medicines for treating digestive system diseases. The traditional Chinese medicine is to have good effect and quick response, and is prepared from Indian buead, glossy ganoderma, Chinese angelica, notoginseng root, mulberry, turtle shell and the like serving as raw materials. The traditional Chinese medicine has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, nourishing the liver, softening hard lumps and dispelling nodes, promoting blood circulation by removing blood stasis, and stopping pain, and has the advantages of obvious effect, define curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The Chinese medicine that is used for the treatment of liver cirrhosis at present, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of liver cirrhosis patient constantly increases the weight of because of the fibrosis of liver, causes complication such as digestive tract hemorrhage, hepatic encephalopathy at last and death.Patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of liver cirrhosis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of liver cirrhosis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Poria 6---18 parts of 18 portions of Ganodermas 6---18 parts of Radix Angelicae Sinensis 6---
Radix Notoginseng 3---18 parts in 9 portions of Fructus Moris 6---18 parts of Carapax Trionycis 6---
The Chinese medicine of this treatment liver cirrhosis is made by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is as follows: Ganoderma is broken into graininess, cross 40 mesh sieves →, concentrate → mixed, leave standstill 10-12 hour, centrifugal → as to add 75% ethanol with 95% ethanol of 3 times of volumes with 1: 20 hot water (95 ℃) lixiviate → lixiviating solution decompression, precipitate polysaccharide → dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Poria, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted through conventional water extraction process, make extract extractum fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, make Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think in research, hypoimmunity, and positive QI-insufficiency is the deciding factor that hepatic fibrosis, liver cirrhosis development take place and lapse to.So this disease " refractory " is referred to as " persistent ailment ", so effect " humble ", obstinate, the underlying cause just are the decisive role to immunity of organisms (setting upright), and not enough on the understanding, dynamics is also little.In view of the above, the present invention attaches most importance to set upright, and in conjunction with the pathological characters of liver cirrhosis behind the liver cirrhosis especially viral hepatitis, adopts the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, hard masses softening and resolving is obtained remarkable result.The significance outstanding behaviours of this curative effect is aspect two: the one, and " dull pain in liver " that is difficult to overcome obviously alleviated, even complete obiteration; The 2nd, " the hepatic fibrosis reverse " that is difficult to realize realizes substantially or fully.Ganoderma, Fructus Mori the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, tonification the five internal organs, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng blood-nourishing blood-generating, promoting blood circulation, removing blood stasis and relieving pain, nourishing the liver easing the affected liver; 5 with the Poria promoting diuresis to eliminate damp pathogen, to suppress hepatic ascites; Carapax Trionycis tonifying YIN and heat extraction, removing blood stasis and hard masses softening and resolving are to alleviate hepatic fibrosis.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, nourishing the liver easing the affected liver, and hard masses softening and resolving, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Poria 60 kairine sesames 60 gram Radix Angelicae Sinensis 60 grams
Radix Notoginseng 30 gram Fructus Moris 60 gram Carapax Trionycis 60 grams
Weight is extracted Ganoderma with decoction and alcohol sedimentation technique in accordance with regulations; With conventional water extraction process Poria, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted, make extract fine powder 60 grams altogether, Radix Notoginseng is ground into fine powder, mix with said extracted thing fine powder, stir, make fine particle, the capsule of packing into No. 0, make 321 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Poria 120 kairine sesames 120 gram Radix Angelicae Sinensis 120 grams
Radix Notoginseng 60 gram Fructus Moris 120 gram Carapax Trionycis 120 grams
By above-mentioned same method, make 642 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Poria 180 kairine sesames 180 gram Radix Angelicae Sinensis 180 grams
Radix Notoginseng 90 gram Fructus Moris 180 gram Carapax Trionycis 180 grams
By above-mentioned same method, make 964 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 7 parts of Radix Angelicae Sinensis of 7 portions of Ganodermas of Poria
7 parts of 7 parts of Carapax Trionycis of 3 portions of Fructus Moris of Radix Notoginseng
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts of 15 parts of Radix Angelicae Sinensis of 15 portions of Ganodermas of Poria
15 parts of 15 parts of Carapax Trionycis of 7 portions of Fructus Moris of Radix Notoginseng
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science liver cirrhosis, through 9 routine clinical observations.Selecting the tcm diagnosis liver cirrhosis is standard: limb is soft weak, and is weak from head to foot; Abdominal distention, nauseating, upper abdomen dull pain; Hepatomegaly, quality are hard partially; Jaundice, anemia or bleeding tendency is arranged; Liver palm, spider angioma, cutaneous pigmentation and edema etc. appear.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 5 examples, women's 4 examples do not have other serious disease, and the age is 53 years old-82 years old, 67.4 years old mean age.
Efficacy determination:
1, produce effects: weak disappearance, limbs are strong; Abdominal distention, feel sick, upper abdomen dull pain obviously alleviates; Anemia and hepatic face are obviously alleviated, and face is pale, occur ruddy; Edema disappears; Hepatic fibrosis inspection index is obviously alleviated.
2, effective: on one's body energetically; Abdominal distention, feel sick, vomiting, anemia, edema etc. alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.9 philtrums of clinical experiment, produce effects 4 people, effective 4 people, invalid 1 people, total effective rate 88.8%.
Claims (1)
1. Chinese medicine for the treatment of liver cirrhosis, it is characterized in that: it is to make with the component of following weight ratio: Poria 6---18 parts, Ganoderma 6---18 parts, Radix Angelicae Sinensis 6---18 parts, Radix Notoginseng 3---9 parts, Fructus Mori 6---18 parts, Carapax Trionycis 6---18 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105144523A CN101953893A (en) | 2010-10-14 | 2010-10-14 | Traditional Chinese medicine for treating cirrhosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105144523A CN101953893A (en) | 2010-10-14 | 2010-10-14 | Traditional Chinese medicine for treating cirrhosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101953893A true CN101953893A (en) | 2011-01-26 |
Family
ID=43481651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105144523A Pending CN101953893A (en) | 2010-10-14 | 2010-10-14 | Traditional Chinese medicine for treating cirrhosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101953893A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614257A (en) * | 2012-03-31 | 2012-08-01 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treatment of cirrhosis |
| CN104740541A (en) * | 2015-04-21 | 2015-07-01 | 杨波 | Health-care traditional Chinese medicine powder for protecting liver, detoxifying and recovering liver functions |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101596230A (en) * | 2009-07-14 | 2009-12-09 | 广西中医学院附属瑞康医院 | A kind of pharmaceutical composition for the treatment of hepatopathy |
| CN101843773A (en) * | 2009-10-22 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating liver cirrhosis |
-
2010
- 2010-10-14 CN CN2010105144523A patent/CN101953893A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101596230A (en) * | 2009-07-14 | 2009-12-09 | 广西中医学院附属瑞康医院 | A kind of pharmaceutical composition for the treatment of hepatopathy |
| CN101843773A (en) * | 2009-10-22 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating liver cirrhosis |
Non-Patent Citations (2)
| Title |
|---|
| 尹镭等: "茯苓对实验性肝硬变的治疗作用", 《山西医科大学学报》 * |
| 李国安等: "参芪二甲散抗肝纤维化的疗效观察", 《辽宁中医杂志》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102614257A (en) * | 2012-03-31 | 2012-08-01 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treatment of cirrhosis |
| CN104740541A (en) * | 2015-04-21 | 2015-07-01 | 杨波 | Health-care traditional Chinese medicine powder for protecting liver, detoxifying and recovering liver functions |
| CN104740541B (en) * | 2015-04-21 | 2019-05-14 | 杨波 | A kind of protecting liver and detoxication restores the Chinese medicine powder for health care of liver function |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843773B (en) | Chinese medicament for treating liver cirrhosis | |
| CN102048831A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102172374A (en) | Traditional Chinese medicine for treating hyperplasia of prostate | |
| CN102091130A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN102172369A (en) | Chinese medicine for treating hepatocirrhosis | |
| CN102379924A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN101953893A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101972349A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102068569A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102114080A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102068529A (en) | Traditional Chinese medicine for treatment of prostatic hyperplasia | |
| CN102302558A (en) | Chinese medicament for treating hepatocirrhosis | |
| CN102389482A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101991652A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN101966230A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102138983A (en) | Traditional Chinese medicine for treating hepatocirrhosis | |
| CN101953891A (en) | Chinese medicament for treating hepatocirrhosis | |
| CN102389477A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN102670725A (en) | Traditional Chinese medicine for curing cirrhosis | |
| CN102389525A (en) | Traditional Chinese medicine for curing benign prostatic hyperplasia | |
| CN102389461A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102389462A (en) | Chinese medicine for treating cirrhosis | |
| CN101843877B (en) | Chinese medicament for treating liver cirrhosis | |
| CN102379923A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101843879B (en) | Chinese medicament for treating liver cirrhosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110126 |